Structure of a BCOR corepressor peptide in complex with the BCL6 BTB domain dimer

被引:138
作者
Ghetu, Alexandru F. [1 ]
Corcoran, Connie M. [2 ]
Cerchietti, Leandro [3 ]
Bardwell, Vivian J. [2 ]
Melnick, Ari [3 ]
Prive, Gilbert G. [1 ,4 ,5 ]
机构
[1] Ontario Canc Inst, Div Canc Genom & Proteom, Toronto, ON M5G 1L7, Canada
[2] Univ Minnesota, Dept Genet Cell Biol & Dev, Ctr Canc, Minneapolis, MN 55455 USA
[3] Yeshiva Univ Albert Einstein Coll Med, Dept Dev & Mol Biol, Bronx, NY 10461 USA
[4] Univ Toronto, Dept Med Biophys, Toronto, ON M5G 2M9, Canada
[5] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada
关键词
D O I
10.1016/j.molcel.2007.12.026
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The transcriptional corepressors BCOR, SMRT, and NCoR are known to bind competitively to the BCL6 BTB domain despite the fact that BCOR has no detectable sequence similarity to the other two corepressors. We have identified a 17 residue motif from BCOR that binds directly to the BCL6 BTB domain and determined the crystal structure of the complex to a resolution of 2.6 angstrom. Remarkably, the BCOR BCL6 binding domain (BCORBBD) peptide binds in the same BCL6 binding site as the SMRTBBD peptide despite the lack of any significant sequence similarity between the two peptides. Mutations of critical BCORBBD residues cause the disruption of the BCL6 corepression activities of BCOR, and a BCORBBD peptide blocks BCL6-mediated transcriptional repression and kills lymphoma cells.
引用
收藏
页码:384 / 391
页数:8
相关论文
共 24 条
[1]   Mechanism of SMRT corepressor recruitment by the BCL6 BTB domain [J].
Ahmad, KF ;
Melnick, A ;
Lax, S ;
Bouchard, D ;
Liu, J ;
Kiang, CL ;
Mayer, S ;
Takahashi, S ;
Licht, JD ;
Privé, GG .
MOLECULAR CELL, 2003, 12 (06) :1551-1564
[2]   Deregulated BCL6 expression recapitulates the pathogenesis of human diffuse large B cell lymphomas in mice [J].
Cattoretti, G ;
Pasqualucci, L ;
Ballon, G ;
Tam, W ;
Nandula, SV ;
Shen, Q ;
Mo, TW ;
Murty, VV ;
Dalla-Favera, R .
CANCER CELL, 2005, 7 (05) :445-455
[3]   Stages of germinal center transit are defined by B cell transcription factor coexpression and relative abundance [J].
Cattoretti, Giorgio ;
Shaknovich, Rita ;
Smith, Paula M. ;
Jack, Hans-Martin ;
Murty, Vundavalli V. ;
Alobeid, Bachir .
JOURNAL OF IMMUNOLOGY, 2006, 177 (10) :6930-6939
[4]   A peptide aptamer to antagonize BCL-6 function [J].
Chattopadhyay, A ;
Tate, SA ;
Beswick, RW ;
Wagner, SD ;
Ferrigno, PK .
ONCOGENE, 2006, 25 (15) :2223-2233
[5]   Corepressor SMRT binds the BTB/POZ repressing domain of the LAZ3/BCL6 oncoprotein [J].
Dhordain, P ;
Albagli, O ;
Lin, RJ ;
Ansieau, S ;
Quief, S ;
Leutz, A ;
Kerckaert, JP ;
Evans, RM ;
Leprince, D .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (20) :10762-10767
[6]   The tryptophan switch: Changing ligand-binding specificity from type I to type II in SH3 domains [J].
Fernandez-Ballester, G ;
Blanes-Mira, C ;
Serrano, L .
JOURNAL OF MOLECULAR BIOLOGY, 2004, 335 (02) :619-629
[7]   Polycomb group and SCF ubiquitin ligases are found in a novel BCOR complex that is recruited to BCL6 targets [J].
Gearhart, Micah D. ;
Corcoran, Connie M. ;
Wamstad, Joseph A. ;
Bardwell, Vivian J. .
MOLECULAR AND CELLULAR BIOLOGY, 2006, 26 (18) :6880-6889
[8]  
Guenther MG, 2000, GENE DEV, V14, P1048
[9]   The BCL-6 POZ domain and other POZ domains interact with the co-repressors N-CoR and SMRT [J].
Huynh, KD ;
Bardwell, VJ .
ONCOGENE, 1998, 17 (19) :2473-2484
[10]  
Huynh KD, 2000, GENE DEV, V14, P1810